{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T10:51:03Z","timestamp":1775645463124,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"9435","license":[{"start":{"date-parts":[[2004,8,1]],"date-time":"2004-08-01T00:00:00Z","timestamp":1091318400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet"],"published-print":{"date-parts":[[2004,8]]},"DOI":"10.1016\/s0140-6736(04)16895-5","type":"journal-article","created":{"date-parts":[[2004,8,27]],"date-time":"2004-08-27T18:36:45Z","timestamp":1093631805000},"page":"685-696","source":"Crossref","is-referenced-by-count":3000,"title":["Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial"],"prefix":"10.1016","volume":"364","author":[{"given":"Helen M","family":"Colhoun","sequence":"first","affiliation":[]},{"given":"D John","family":"Betteridge","sequence":"additional","affiliation":[]},{"given":"Paul N","family":"Durrington","sequence":"additional","affiliation":[]},{"given":"Graham A","family":"Hitman","sequence":"additional","affiliation":[]},{"given":"H Andrew","family":"W Neil","sequence":"additional","affiliation":[]},{"given":"Shona J","family":"Livingstone","sequence":"additional","affiliation":[]},{"given":"Margaret J","family":"Thomason","sequence":"additional","affiliation":[]},{"given":"Michael I","family":"Mackness","sequence":"additional","affiliation":[]},{"given":"Valentine","family":"Charlton-Menys","sequence":"additional","affiliation":[]},{"given":"John H","family":"Fuller","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0140-6736(04)16895-5_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care"},{"key":"10.1016\/S0140-6736(04)16895-5_bib2","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.1161\/01.STR.0000102901.41780.5C","article-title":"Is diabetes mellitus a cardiovascular disease risk equivalent for fatal stroke in women? Data from the Women's Pooling Project","volume":"34","author":"Ho","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/S0140-6736(04)16895-5_bib3","first-page":"12","article-title":"The incidence and aetiology of stroke in the Caerphilly and Speedwell Collaborative Studies II: risk factors for ischaemic stroke","volume":"115","author":"McCarron","year":"2001","journal-title":"Public Health"},{"key":"10.1016\/S0140-6736(04)16895-5_bib4","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2337\/diacare.20.5.704","article-title":"The impact of diabetes on survival among patients with first myocardial infarction","volume":"20","author":"Chun","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/S0140-6736(04)16895-5_bib5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1136\/hrt.74.3.324","article-title":"Factors determining case fatality in myocardial infarction \u201cwho dies in a heart attack\u201d?","volume":"74","author":"Wannamethee","year":"1995","journal-title":"Br Heart J"},{"key":"10.1016\/S0140-6736(04)16895-5_bib6","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0895-4356(02)00572-3","article-title":"Stroke subtype and mortality a follow-up study in 998 patients with a first cerebral infarct","volume":"56","author":"de Jong","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S0140-6736(04)16895-5_bib7","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/bmj.316.7134.823","article-title":"Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23)","volume":"316","author":"Turner","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(04)16895-5_bib8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/CS20000335","article-title":"The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56)","volume":"101","author":"Stevens","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/S0140-6736(04)16895-5_bib9","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.STR.0000020091.07144.C7","article-title":"UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine","volume":"33","author":"Kothari","year":"2002","journal-title":"Stroke"},{"key":"10.1016\/S0140-6736(04)16895-5_bib10","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2337\/diacare.20.4.614","article-title":"Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease: a subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)","volume":"20","author":"Pyorala","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/S0140-6736(04)16895-5_bib11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S0140-6736(04)16895-5_bib12","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1161\/01.CIR.98.23.2513","article-title":"Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial","volume":"98","author":"Goldberg","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(04)16895-5_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(04)16895-5_bib14","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(04)16895-5_bib15","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(04)16895-5_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.291.3.335","article-title":"Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes","volume":"291","author":"Saydah","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S0140-6736(04)16895-5_bib17","first-page":"R73","article-title":"Application of evidence-based criteria of appropriate aspirin and appropriate lipid-lowering therapy in diabetic inpatients","volume":"11","author":"Oborne","year":"2003","journal-title":"Int J Pharmacy Practice"},{"issue":"suppl 2","key":"10.1016\/S0140-6736(04)16895-5_bib18","first-page":"A285","article-title":"The AUDIT Study: a worldwide survey of physicians attitudes about diabetic dyslipidaemia","volume":"53","author":"Leiter","year":"2004","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.1016\/S0140-6736(04)16895-5_bib19","first-page":"S68","article-title":"Dyslipidemia management in adults with diabetes","volume":"27","author":"Haffner","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S0140-6736(04)16895-5_bib20","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00149831-200312001-00001","volume":"10","author":"De Backer","year":"2003","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/S0140-6736(04)16895-5_bib21","first-page":"3112","article-title":"Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines","volume":"109","author":"Grundy","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/S0140-6736(04)16895-5_bib22","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1046\/j.1464-5491.2002.00643.x","article-title":"Design of the Collaborative AtoRvastatin Diabetes Study (CARDS) in patients with type 2 diabetes","volume":"19","author":"Colhoun","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/S0140-6736(04)16895-5_bib23","series-title":"Lipoprotein analysis: a practical approach","article-title":"Lipoprotein separation and analysis for clinical studies","author":"Mackness","year":"1992"},{"key":"10.1016\/S0140-6736(04)16895-5_bib24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/S0140-6736(04)16895-5_bib25","series-title":"Handbook of lipoprotein testing","first-page":"221","article-title":"Measurement of high-density lipoprotein cholesterol","author":"Nauck","year":"2000"},{"key":"10.1016\/S0140-6736(04)16895-5_bib26","first-page":"24","article-title":"Clinical trial methodology","volume":"28","author":"Peto","year":"1978","journal-title":"Biomedicine"},{"key":"10.1016\/S0140-6736(04)16895-5_bib27","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0140-6736(98)03454-0","article-title":"Blood pressure, cholesterol, and stroke in eastern Asia","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(04)16895-5_bib28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1093\/ije\/dyg106","article-title":"Cholesterol, coronary heart disease, and stroke in the Asia Pacific region","volume":"32","author":"Zhang","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S0140-6736(04)16895-5_bib29","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/S0140-6736(04)15690-0","article-title":"Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S0140-6736(04)16895-5_bib30","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/bmj.324.7343.939","article-title":"Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies","volume":"324","author":"Evans","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/S0140-6736(04)16895-5_bib31","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0002-9149(99)80744-9","article-title":"Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens","volume":"75","year":"1995","journal-title":"Am J Cardiol"}],"container-title":["The Lancet"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673604168955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0140673604168955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T01:51:24Z","timestamp":1585878684000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0140673604168955"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,8]]},"references-count":31,"journal-issue":{"issue":"9435","published-print":{"date-parts":[[2004,8]]}},"alternative-id":["S0140673604168955"],"URL":"https:\/\/doi.org\/10.1016\/s0140-6736(04)16895-5","relation":{},"ISSN":["0140-6736"],"issn-type":[{"value":"0140-6736","type":"print"}],"subject":[],"published":{"date-parts":[[2004,8]]}}}